Full Text Article

Concomitant Finding of a Large Vessel Vasculitis and a Colorectal Neoplasia on FDG PET/CT

Received Date: June 08, 2022 Accepted Date: July 11, 2022 Published Date: July 13, 2022

doi: 10.17303/jrnm.2022.2.101

Citation: Kargar Samani I, Krug B, Pirson AS and Vander Borght T (2022) Concomitant Finding of a Large Vessel Vasculitis and a Colorectal Neoplasia on FDG PET/CT. J Radiol Nucl Med 2: 1-3

A 64-year-old female patient underwent an F-18 fluorodeoxyglucose positron emitting tomography/computed tomography (FDG PET/CT) for evaluation of inflammation not responding to steroid therapy in the setting of suspected polymyalgia rheumatica. A hypermetabolic mass was found at the rectosigmoid junction associated with hypermetabolic hepatic hypodense lesions as well as a hypermetabolic thickening of large vessels’ wall (aorta, carotids, subclavian arteries, axillary arteries, iliac arteries and femoral arteries). In this setting, we suspected the vasculitis to be paraneoplastic.

Keywords: Large Vessel Vasculitis, F-18 fluorodeoxyglucose, Paraneoplastic, Cancer

Paraneoplastic vasculitis is a rare condition that has not been frequently described mainly because of the difficulty to establish a causal relationship between cancer and vasculitis [1]. They account for 2 to 5% of all vasculitides [1]. They predominantly affect small and medium vessels, the most common vasculitis being leukocytoclastic vasculitis, and seem to be more often related to hematologic neoplasms with a proven association between hairy cell leukemia and polyarteritis nodosa [1,2]. Nonetheless, there have been a few articles reporting associations between large vessels vasculitis and hematologic cancers such as chronic myeloid leukemia [3,4], chronic myelomonocytic leukemia [5] and myelodysplastic syndrome [6] and there was one case report of an aortitis as a paraneoplastic syndrome of a colon adenocarcinoma [7]. Response to treatment appears to be very inconsistent with some patients showing a rapid response to steroid therapy and others relapsing [5,6], some never showing any improvement in the first place and needing specific treatment of the underlying malignancy [7]. In our case, the patient was not showing much response to steroid therapy either, but after initiating chemotherapy, C-reactive protein started declining, going from 102 mg/L to 19 mg/L in a month and dwindling to 5.8 mg/L the following month, which gave weight to the diagnosis of paraneoplastic vasculitis.

Consent was obtained from the patient.

Here you will find the contributions of all co-authors: Isaac Kargar Samani (1,2), Bruno Krug (1,2), Anne-Sophie Pirson (2) and Thierry Vander Borght (1,2). They are based on the following criteria published in the guide for authors:  drafting the article or revising it critically for important intellectual content (1) and final approval of the version to be submitted (2).

The authors have no conflicts of interest to disclose.

  1. Azar L, Khasnis A (2013) Paraneoplastic Rheumatologic syndromes. Curr Opin Rheumatol 25: 44-9.
  2. Kermani TA, Warrington KJ, Amin S (2011) Malignancy risk in vasculitis. Ther Adv Musculoskelet Dis 3: 55-63.
  3. Yuce Inel T, Gulcu A, Karakas A, Erdogan Yucel E, Onen F (2021) Coexistence of Takayasu arteritis and chronic myeloid leukemia: Coincidental or paraneoplastic phenomenon? Int J Rheum Dis. 24: 1213-1216.
  4. Park JK, Gelber AC, Zheng G, McDevitt MA, Gocke CD, Baer AN (2011) Large-vessel vasculitis as an early manifestation of chronic myelomonocytic leukemia. J Clin Oncol 29: e601-603.
  5. Sasinowska S, Traisak P, McCormack M, Eid H (2017) A Rare Case of Paraneoplastic Aortitis Associated with Chronic Myelomonocytic Leukemia. Case Rep Hematol. 2017: 3091973.
  6. Yabe H (2018) Paraneoplastic Large-vessel Vasculitis Associated with Myelodysplastic Syndrome. Intern Med. 57: 2769-2771.
  7. O'Connell EW, Reams J, Denio AE (2019) Aortitis as a Harbinger of Occult Malignancy. Case Rep Rheumatol. 2019: 8385630.
CommentsFigure 1